Reduction of solar lentigines Solar lentigines laser hyperpigmentation aging spot
Conditions
Interventions
treated with this device once,treated with this device once
Active Comparator Device,Experimental Device
KTP 532-nm picosecond laser,Alexandrite 755-nm picosecond laser
Sponsors
Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Subjects had at least two similar solar lentigines with the diameter more than 5 mm at either arm.
Exclusion criteria
Exclusion criteria: were patients with other skin diseases including active skin infection, skin inflammation and wound, those who received any topical medication or laser therapy 3 month prior to the enrollment, immunocompromised patients or currently on isotretinoin or immunosuppressive agents, those who had a previous history of keloid and skin cancer, and pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean luminance score evaluate at every visit colorimeter (DSM II ColorMeter) | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement score evaluate at every visit 5-point rating scale | — |
Countries
Thailand
Contacts
Public ContactVasanop Vachiramon
Faculty of Medicine, Ramathibodi hospital
Outcome results
None listed